Clinical Trial Update: Primary Prevention Hepatocellular Carcinoma by Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating metformin for primary prevention of hepatocellular carcinoma in people with chronic liver disease, including chronic hepatitis C and ci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Hepatitis C
• Hepatocellular Carcinoma

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hepatocellular Carcinoma, Hepatitis C, Chronic | Phase 3 | Status: TERMINATED